US President Donald Trump on Wednesday laid out a phased tariff plan for imported generic medicines, giving drugmakers a two-year window to shift manufacturing to the United States before steep duties kick in. In a post on Truth Social, Trump said generic drugs entering the US would stay tariff-free from August 1, 2026, for two years. After that, a 100 percent tariff would apply from August 2028, rising further to 200 percent from August 2029. He further added that the plan is meant to push pharmaceutical companies to set up generic drug manufacturing within the US, calling the rising tariffs a penalty for firms that don't build plants domestically in time.
RSS News
India TV News
0 thoughts on “How does Trump's tariff on generic drugs, from 2028 onwards, affect India's pharma sector?”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- “We’re told they…”: Candace Owens challenges Andrew Kolvet with ‘retraction’ demand in escalating Charlie Kirk feud
- US, Saudi Arabia sign civil nuclear deal paving way for uranium enrichment
- D4vd preliminary hearing: Celeste Rivas' family lawyer describes 'gruesome' crime scene photos
- Quote of the day by Laozi: 'A good traveler has no fixed plans and is not intent on arriving'
- Quote by Che Guevara: 'The life of a single human being is worth millions of times more than...'
